BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/21/2026 9:00:12 AM | Browse: 5 | Download: 11
 |
Received |
|
2026-01-19 02:01 |
|
Peer-Review Started |
|
2026-01-19 02:01 |
|
First Decision by Editorial Office Director |
|
2026-01-23 08:02 |
|
Return for Revision |
|
2026-01-23 08:02 |
|
Revised |
|
2026-02-05 04:36 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2026-03-18 02:37 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-03-18 08:35 |
|
Articles in Press |
|
2026-03-18 08:35 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-04-02 08:07 |
|
Publish the Manuscript Online |
|
2026-04-21 09:00 |
| ISSN |
2218-4333 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© Author(s) (or their employer(s)) 2026. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Editorial |
| Article Title |
Clinicopathological disparities and prognostic implications of palpable vs non-palpable breast cancer: Toward precision multi-modal early screening strategies
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Yu-Tong Han, Yue-Chuan Jiao, Chang Qiao, Hao-Wei Li and De-Hui Li |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| the Natural Science Foundation of Hebei Province |
H2024423105 |
| 2023 Government Funded Project of the Outstanding Talents Training Program in Clinical Medicine |
ZF2023165 |
| Key Research and Development Projects of Hebei Province |
18277731D |
| Hebei Provincial Administration of Traditional Chinese Medicine, Scientific Research Project |
2023045 |
| Hebei Provincial Administration of Traditional Chinese Medicine, Scientific Research Project |
2024023 |
| Hebei Institute of Traditional Chinese Medicine Pharmaceutical Preparation Industry Technology Special Project |
YJY2024006 |
| Scientific Research Project of Health Commission of Hebei Province |
20220962 |
| Scientific Research Project of Health Commission of Hebei Province |
20240282 |
|
| Corresponding Author |
De-Hui Li, Department of Oncology II, The First Affiliated Hospital of Hebei University of Chinese Medicine, Hebei Province Hospital of Chinese Medicine, Key Laboratory of Integrated Chinese and Western Medicine for Gastroenterology Research, Hebei Industrial Technology Institute for Traditional Chinese Medicine Preparation, No. 389 Zhongshan East Road, Chang’an District, Shijiazhuang 050000, Hebei Province, China. 258289951@qq.com |
| Key Words |
Breast cancer; Breast screening; Palpable tumor; Non-palpable tumor; Prognosis difference |
| Core Tip |
This paper focuses on the differences between palpable and non-palpable tumors in breast cancer screening. The former is more invasive and early screening is crucial for improving prognosis. Multiple combined technologies, risk stratification screening, and the concept of “preventing disease before it occurs” can optimize the prevention and control effect. |
| Publish Date |
2026-04-21 09:00 |
| Citation |
Han YT, Jiao YC, Qiao C, Li HW, Li DH. Clinicopathological disparities and prognostic implications of palpable vs non-palpable breast cancer: Toward precision multi-modal early screening strategies. World J Clin Oncol 2026; 17(4): 119059 |
| URL |
https://www.wjgnet.com/2218-4333/full/v17/i4/119059.htm |
| DOI |
https://dx.doi.org/10.5306/wjco.v17.i4.119059 |
© 1993-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
